Rockefeller Capital Management L.P. Cuts Stock Holdings in Cognex Corporation $CGNX

Rockefeller Capital Management L.P. reduced its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 61.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 24,336 shares of the scientific and technical instruments company’s stock after selling 39,267 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Cognex were worth $876,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Geneos Wealth Management Inc. lifted its stake in shares of Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the last quarter. CIBC Private Wealth Group LLC grew its position in Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the last quarter. Miller Global Investments LLC purchased a new position in Cognex in the 4th quarter worth approximately $39,000. Caitong International Asset Management Co. Ltd purchased a new position in Cognex in the 4th quarter worth approximately $39,000. Finally, Larson Financial Group LLC increased its stake in Cognex by 202.7% in the 4th quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after purchasing an additional 740 shares during the period. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Insider Transactions at Cognex

In other news, VP Laura Ann Macdonald sold 98,122 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $66.80, for a total value of $6,554,549.60. Following the completion of the transaction, the vice president owned 5,258 shares of the company’s stock, valued at approximately $351,234.40. This represents a 94.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Darren Marc Long sold 20,252 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. This trade represents a 83.54% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 224,847 shares of company stock valued at $14,975,098. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Stephens increased their price objective on Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Needham & Company LLC lifted their target price on shares of Cognex from $67.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Robert W. Baird set a $72.00 price target on shares of Cognex in a report on Friday, May 8th. UBS Group set a $75.00 price target on shares of Cognex in a research report on Tuesday, May 26th. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $75.00 price target on shares of Cognex in a research report on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $71.14.

Cognex Stock Performance

Shares of CGNX stock opened at $67.80 on Friday. Cognex Corporation has a fifty-two week low of $31.77 and a fifty-two week high of $72.88. The firm has a market cap of $11.28 billion, a P/E ratio of 80.71 and a beta of 1.49. The business’s 50 day moving average price is $63.52 and its 200-day moving average price is $52.30.

Cognex (NASDAQ:CGNX) last announced its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same quarter in the prior year, the company earned $0.14 earnings per share. The firm’s revenue for the quarter was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, equities analysts predict that Cognex Corporation will post 1.49 EPS for the current year.

Cognex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Investors of record on Thursday, May 21st were given a dividend of $0.085 per share. The ex-dividend date was Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s payout ratio is currently 40.48%.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.